BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FXYD4
,
Apoptosis
,
Pseudomonas infection
,
Lung
,
Nosology
,
Prozac
,
rs2476601
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
myeloid dendritic cell activation
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Disease due to Togaviridae
Contact dermatitis
Toxoplasmosis
Vesicular stomatitis Indiana virus disease
Coronavirus infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
myelin oligodendrocyte glycoprotein
CGP 60474
A 443654
AT 7519
ARQ 197
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
INSM2
ANKRD2
RPP38
CD46
TLK2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Lung gene expression in ovalbumin (OVA)-induced experimental asthma
L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
All spinal cord cells or spinal motor neurons with experimental autoimmune encephalomyelitis
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Prion protein: a pattern recognition receptor for viral components and uric acid responsible for the…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Sargramostim for Myeloid Dendritic Cell Deficiency
Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes
Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma
Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherpar…
Sargramostim for Myeloid Dendritic Cell Deficiency
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ